October 2016 – Drug and Device Digest

FDA-EMA Patient Engagement Cluster

Image result for FDA-EMA Cluster image

WHAT: Cluster to share best practices involving patients along drug and biologic regulatory lifecycles

WHY: Broadened approach to advance and strengthen international collaboration

WHO: FDA and European Medicines Agency (EMA)

HOW:  Meet up to four times per year

  • Learn how their respective patients are engaged and involved
  • Develop common goals of expanding future patient engagement activities



Scroll to Top